Treatment of newly diagnosed acute promyelocytic leukemia (APL): A comparison between French-Belgian-Swiss and Spanish results.

被引：0
|
作者：
Ades, L
Sanz, M
Chevret, S
De Botton, S
Martin, G
Raffoux, E
Vellenga, E
Guerci, A
Gonzalez, M
Pigneux, A
Rayon, C
Stoppa, AM
De la Serna, J
Pabst, T
Meyer-Monard, S
Parodi, R
Bergua, J
Rigal-Huguet, F
Vekhoff, A
Negri, S
Fegueux, N
Ferrant, A
Bron, D
Dombret, H
Degos, L
Fenaux, P
机构：
[1] Univ Paris 13, Hop Avicenne, Bobigny, France
[2] PETHEMA, Valencia, Spain
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
544
引用
收藏
页码：162A / 162A
页数：1
相关论文
共 50 条
  • [1] Treatment of newly diagnosed acute promyelocytic leukemia (APL):: a comparison of French-Belgian-Swiss and PETHEMA results
    Ades, Lionel
    Sanz, Miguel A.
    Chevret, Sylvie
    Montesinos, Pau
    Chevallier, Patrice
    Raffoux, Emmanuel
    Vellenga, Edo
    Guerci, Agnbs
    Pigneux, Arnaud
    Huguet, Francoise
    Rayon, Consuelo
    Stoppa, Anne Marie
    de la Serna, Javier
    Cahn, Jean-Yves
    Meyer-Monard, Sandrine
    Pabst, Thomas
    Thomas, Xavier
    de Botton, Stephane
    Parody, Ricardo
    Bergua, Juan
    Lamy, Thierry
    Vekhoff, Anne
    Negri, Silvia
    Ifrah, Norbert
    Dombret, Herve
    Ferrant, Augustin
    Bron, Dominique
    Degos, Laurent
    Fenaux, Pierre
    BLOOD, 2008, 111 (03) : 1078 - 1084
  • [2] Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) in the Elderly: A Joint Analysis of the French -Belgian-Swiss and PETHEMA
    Ades, Lionel
    Montesinos, Pau
    Chevret, Sylvie
    Vellenga, Edo
    Raffoux, Emmanuel
    Rayon, Chelo
    Diaz-Mediavilla, Joaquim
    Thomas, Xavier
    Chevallier, Patrice
    Rivas, Concha
    Guerci, Agnes
    Amutio, Elena
    Huguet, Francoise
    Arias, Jesus
    Vey, Norbert
    Deben, Guillermo
    Meyer, Sandrine
    Novo, Andres
    Ferrant, Augustin
    Bergua, Juan
    Rigon, Mathieu Resche
    de la Serna, Javier
    Dombret, Herve
    Castaigne, Sylvie
    Fenaux, Pierre
    Sanz, Miguel A.
    BLOOD, 2009, 114 (22) : 348 - 348
  • [3] Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group
    Braun, Thorsten
    Cereja, Sophie
    Chevret, Sylvie
    Raffoux, Emmanuel
    Beaumont, Marie
    Detourmignies, Laurence
    Pigneux, Arnaud
    Thomas, Xavier
    Bordessoule, Dominique
    Guerci, Agnes
    Lamy, Thierry
    Recher, Christian
    Poire, Xavier
    Tournilhac, Olivier
    Spertini, Olivier
    Chomienne, Christine
    Degos, Laurent
    Dombret, Herve
    Ades, Lionel
    Fenaux, Pierre
    CANCER, 2015, 121 (14) : 2393 - 2399
  • [4] Recent Results of the French Belgian Swiss Acute Promyelocytic Leukemia (APL) Group
    Ades, L.
    Fenaux, P.
    ANNALS OF HEMATOLOGY, 2011, 90 : S45 - S48
  • [5] Treatment of acute promyclocytic leukemia (APL)-An update of the French-Belgian-Swiss group experience
    Ades, L.
    Fenaux, P.
    ANNALS OF HEMATOLOGY, 2008, 87 : S21 - S23
  • [6] Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group
    Ades, Lionel
    Thomas, Xavier
    Bresler, Agnes Guerci
    Raffoux, Emmanuel
    Spertini, Olivier
    Vey, Norbert
    Marchand, Tony
    Recher, Christian
    Pigneux, Arnaud
    Girault, Stephane
    Deconinck, Eric
    Gardin, Claude
    Tournilhac, Olivier
    Lambert, Jean Francois
    Chevallier, Patrice
    de Botton, Stephane
    Lejeune, Julie
    Dombret, Herve
    Chevret, Sylvie
    Fenaux, Pierre
    HAEMATOLOGICA, 2018, 103 (12) : 2033 - 2039
  • [7] Treatment of newly diagnosed patients with acute promyelocytic leukemia with modified spanish treatment protocol
    Oravcova, I.
    Czako, B.
    Demeckova, E.
    Demitrovicova, L.
    Greksak, R.
    Kotoucek, P.
    Mego, M.
    Mikuskova, E.
    Richterova, K.
    Al Sabti, F.
    Mistrik, M.
    NEOPLASMA, 2010, 57 (03) : 270 - 279
  • [8] GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children
    Testi, AM
    Biondi, A
    Lo Coco, F
    Moleti, ML
    Giona, F
    Vignetti, M
    Menna, G
    Locatelli, F
    Pession, A
    Barisone, E
    De Rossi, G
    Diverio, D
    Micalizzi, C
    Aricò, M
    Basso, G
    Foa, R
    Mandelli, F
    BLOOD, 2005, 106 (02) : 447 - 453
  • [9] Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial)
    Rahme, Ramy
    Ades, Lionel
    Thomas, Xavier
    Guerci-Bresler, Agnes
    Pigneux, Arnaud
    Vey, Norbert
    Raffoux, Emmanuel
    Castaigne, Sylvie
    Spertini, Olivier
    Wittnebel, Sebastian
    Marolleau, Jean Pierre
    Damaj, Gandhi
    Bordessoule, Dominique
    Lejeune, Julie
    Chevret, Sylvie
    Fenaux, Pierre
    HAEMATOLOGICA, 2018, 103 (11) : E519 - E521
  • [10] Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group
    Ades, Lionel
    Thomas, Xavier
    Cuerci-Bres, Agnes
    Emmanuel, Raffoux
    Spertini, Olivier
    Vey, Norbert
    Lamy, Thierry
    Recher, Christian
    Pigneux, Arnaud
    Bordessoule, Dominique
    Deconincki, Eric
    Cardin, Claude
    Tournilhac, Olivier
    Lambert, Jean-Francois
    Chevallier, Patrice
    de Botton, Stephane
    Lejeune, Julie
    Dombret, Herve
    Chevret, Sylvie
    Fenaux, Pierre
    BLOOD, 2015, 126 (23)
12345